For research use only. We do not sell to patients.
Paltimatrectinib
CAS No. : 2353522-15-1
Biological Activity：Paltimatrectinib (compound I-147) is a potent tyrosine kinase inhibitor with an IC50 of <10 nM for tropomyosin kinases A (TrkA). Paltimatrectinib has the potential for cancer and inflammatory diseases.
Research Area：Cancer|Inflammation/Immunology
Targets：Tyrosinase|Trk Receptor
Related Screening Libraries:Bioactive Compound Library Plus;
Related Small Molecules:hTrkA-IN-1;Dihydromorin;IHMT-TRK-284;ANA-12;Mirificin;XMD16-5;Ac-[Nle4,D-Phe7]-α-MSH (4-10)-NH2;D-Tyrosine-d7;Tetrapeptide-30;D-Tyrosine-d4;Larotrectinib sulfate;5-Feruloylquinic acid;Mulberroside A;N-Acetyl-5-hydroxytryptamine;Tyrosinase-IN-6;LM22B-10;D5261;3′,4′-Dihydroxyacetophenone;N-Acetyl-5-hydroxytryptamine-d3;(±)-Taxifolin;7,8-Dihydroxyflavone;TRK-IN-18;Tyrosinase (206-214), human;TRK-IN-12;Chetoseminudin B;CH7057288;Entrectinib;Benzoyloxypaeoniflorin;Pan-Trk-IN-3
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
